Idiopathic inflammatory myopathies (IIM), also known as myositis, are a heterogeneous
group of autoimmune disorders with varying clinical manifestations, treatment responses …

Inflammatory disorders of the skeletal muscle include polymyositis (PM), dermatomyositis
(DM),(immune mediated) necrotizing myopathy (NM), overlap syndrome with myositis …

Background Intravenous immune globulin (IVIG) for the treatment of dermatomyositis has not
been extensively evaluated. Methods We conducted a randomized, placebo-controlled trial …

Idiopathic inflammatory myopathies (IIM) are a heterogenous family of diseases that can
affect the muscles, skin, lungs, and joints. There have been prior attempts to classify IIMs …

Objective To assess the safety and efficacy of rituximab in a randomized, double‐blind,
placebo‐phase trial in adult and pediatric myositis patients. Methods Adults with refractory …

To develop response criteria for adult dermatomyositis (DM) and polymyositis (PM). Expert
surveys, logistic regression, and conjoint analysis were used to develop 287 definitions …

Polymyositis (PM) and dermatomyositis (DM) are idiopathic inflammatory myopathies (IIMs)
with an autoimmune pathogenesis. Typical features are subacute-onset, proximal …

The idiopathic inflammatory myopathies, including adult and juvenile dermatomyositis (DM),
polymyositis (PM), and inclusion body myositis (IBM), are rare systemic autoimmune …

The idiopathic inflammatory myopathies (IIM s) are a heterogeneous group of diseases,
collectively termed myositis, sharing symptoms of muscle weakness, fatigue and …

Objective To identify the clinical and laboratory predictors of clinical improvement in a cohort
of myositis patients treated with rituximab. Methods We analyzed data for 195 patients with …